|
Q4 FY2024
As of Nov 30, 2024
|
Q4 FY2023
As of Nov 30, 2023
|
Q4 FY2022
As of Nov 30, 2022
|
Q4 FY2021
As of Nov 30, 2021
|
Q4 FY2020
As of Nov 30, 2020
|
Q4 FY2019
As of Nov 30, 2019
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets | ||||||
| Cash | ||||||
| Cash equivalent held in escrow | ||||||
| Bonds and money market funds | ||||||
| Trade and other receivables | ||||||
| Tax credits and grants receivable | ||||||
| Tax credits receivable | ||||||
| Income taxes receivable | ||||||
| Deferred tax assets | ||||||
| Inventories | ||||||
| Prepaid expenses and deposits | ||||||
| Derivative financial assets | ||||||
| Total current assets | ||||||
| Non-current assets | ||||||
| Bonds and money market funds | ||||||
| Property and equipment | ||||||
| Right-of-use-assets | ||||||
| Intangible assets | ||||||
| Deferred financing costs | ||||||
| Other asset | ||||||
| Deferred tax assets | ||||||
| Deferred financing and transaction costs | ||||||
| Total non-current assets | ||||||
| Total assets | ||||||
| Liabilities | ||||||
| Current liabilities | ||||||
| Accounts payable and accrued liabilities | ||||||
| Provisions | ||||||
| Convertible unsecured senior notes | ||||||
| Term loan current | ||||||
| Current portion of Loan Facility | ||||||
| Current portion of long-term debt | ||||||
| Current portion of lease liabilities | ||||||
| Marathon Warrants | ||||||
| Income taxes payable | ||||||
| Deferred revenue | ||||||
| Total current liabilities | ||||||
| Non-current liabilities | ||||||
| Loan Facility | ||||||
| Loan-term debt | ||||||
| Lease liabilities | ||||||
| Other liabilities | ||||||
| Total non-current liabilities | ||||||
| Total liabilities | ||||||
| Equity | ||||||
| Share capital, warrants and subscription receipts | ||||||
| Equity component of convertible unsecured senior notes | ||||||
| Contributed surplus | ||||||
| Deficit | ||||||
| Accumulated other comprehensive income | ||||||
| Total equity | ||||||
| Total liabilities and equity | ||||||
Loading...
